Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2005-10-13
2008-08-26
Flood, Michele C. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C514S866000, C536S005000
Reexamination Certificate
active
07416744
ABSTRACT:
The invention relates inter alia to pharmaceutical compositions containing an extract obtainable from a plant of the genusTrichocaulonorHoodiahaving anti-diabetic activity; and to the use of such extracts and to compound (1) as herein defined and its analogues for the manufacture of medicaments having anti-diabetic activity.
REFERENCES:
patent: 4062950 (1977-12-01), Frommer et al.
patent: 4185116 (1980-01-01), Barnish et al.
patent: 4302447 (1981-11-01), Horrobin
patent: 4302477 (1981-11-01), Mendy et al.
patent: 4393049 (1983-07-01), Horrobin
patent: 4584289 (1986-04-01), Jarreau et al.
patent: 4652553 (1987-03-01), Hagmann et al.
patent: 4882315 (1989-11-01), Chiodini et al.
patent: 4883410 (1989-11-01), Goddard et al.
patent: 4931463 (1990-06-01), Barbier et al.
patent: 5037831 (1991-08-01), Malamas
patent: 5066659 (1991-11-01), Lipinski
patent: 5091418 (1992-02-01), Sawada et al.
patent: 5091524 (1992-02-01), Vértesy et al.
patent: 5157116 (1992-10-01), Ducep et al.
patent: 5175154 (1992-12-01), Schwartz et al.
patent: 5175186 (1992-12-01), Barbier et al.
patent: 5192772 (1993-03-01), Yoshikuni et al.
patent: 5217877 (1993-06-01), Sawada et al.
patent: 5246960 (1993-09-01), Barbier et al.
patent: 5252572 (1993-10-01), Hermecz et al.
patent: 5270342 (1993-12-01), Brittain et al.
patent: 5364636 (1994-11-01), Ochi
patent: 5430060 (1995-07-01), Brittain et al.
patent: 5447946 (1995-09-01), Kurono et al.
patent: 5504078 (1996-04-01), Ducep et al.
patent: 5516516 (1996-05-01), Cherksey
patent: 5605698 (1997-02-01), Ueno
patent: 5693327 (1997-12-01), Shah
patent: 5698199 (1997-12-01), Mori et al.
patent: 5728704 (1998-03-01), Mylari et al.
patent: 5798101 (1998-08-01), Haveson
patent: 5824668 (1998-10-01), Rubinfeld et al.
patent: 5866578 (1999-02-01), Mylari et al.
patent: 5908609 (1999-06-01), Lee et al.
patent: 6100048 (2000-08-01), Cone et al.
patent: 6309853 (2001-10-01), Friedman et al.
patent: 6376657 (2002-04-01), Van Heerden et al.
patent: 6488967 (2002-12-01), Hakkinen et al.
patent: 7033616 (2006-04-01), Rubin et al.
patent: 2002/0146468 (2002-10-01), Rubin et al.
patent: 00069439 (1983-01-01), None
patent: 0101383 (1984-02-01), None
patent: 0123456 (1984-10-01), None
patent: 0154639 (1985-09-01), None
patent: 0218953 (1987-04-01), None
patent: 0219156 (1987-04-01), None
patent: 0224151 (1987-06-01), None
patent: 0296574 (1988-12-01), None
patent: 0749657 (1996-12-01), None
patent: 0703731 (1998-04-01), None
patent: 1 099 444 (2001-05-01), None
patent: 2 771 105 (1999-05-01), None
patent: P 99 02670 (2000-02-01), None
patent: P 98 03039 (2000-09-01), None
patent: 58194818 (1983-11-01), None
patent: 8832028 (1996-12-01), None
patent: WO 85 00970 (1985-03-01), None
patent: WO 90 14827 (1990-12-01), None
patent: WO 94 24149 (1994-10-01), None
patent: WO 95 00041 (1995-01-01), None
patent: WO 95 00161 (1995-01-01), None
patent: 96/39384 (1996-12-01), None
patent: WO 97 15671 (1997-05-01), None
patent: WO 97 47316 (1997-12-01), None
patent: WO 98 10068 (1998-03-01), None
patent: WO 98 20121 (1998-05-01), None
patent: WO 98 27113 (1998-06-01), None
patent: WO 98 28335 (1998-07-01), None
patent: WO 98 42747 (1998-10-01), None
patent: WO 98/46243 (1998-10-01), None
The Merck Manual of Diagnosis and Therapy, 17thEdition, 1999. Editor, Keryn A.G. Lane. Merck & Co., Inc., Chapter 13, “Disorders of Carbohydrate Metabolism”, pp. 165-185; and p. 1902.
Habeck M. Drug Discovery Today (Mar. 1, 2002), 7(5): 280-281. A succulent cure to end obesity.
Davies M J et al., Diabetic Medicine (May 2004), 21(5): 403-414. Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting.
Sturis, J et al., American J of Physiology (1995), 269(4Pt 1):E786-92. Prevention of diabetes does not completely prevent insulin secretion defects in the ZDF rat.
Namiki et al., “Studies on the alpha-glucoside hydrolase inhibitor, adiposin”,J. Antiobiotics, 35, pp. 1234-1236, (1982).
J. B. Clark et al., “The diabetic Zucker fatty rat”,Proc. Soc. Exp. Biol. Med.173, pp. 68-75, (1983).
Richard G. Peterson, “alpha-Glucosidase inhibitors in diabetes: lessons from animal studies”, European Journal of Clinical Investigation, 24, Suppl. 3, 11-18 (1994).
J. H. Johnson et al., “Underexpression of beta cell high Kmglucose transporters in non-insulin dependent diabetes”,Science, 250, pp. 546-549, (1990).
Y. Lee et al., “Beta-cell lipotoxicity in the pathogenesis of non-insulin dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships”,Proc. Natl. Acad. Sci. USA, 91(23), pp. 10878-10882, (1994).
J. L. Milburn et al., “Beta-cell GLUT-2 loss and non-insulin dependent diabetes mellitus: current status of the hypothesis”, (Review)Diabetes Metab, Rev., 9(3), pp. 231-236, (1993).
T. R. Pieber et al., “Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia”,Am. J. Physiol., 265(3 Pt. 1), pp. E446-E453, (1993).
L. J. Slieker et al., “Glucose transporter levels in tissues of spontaneously diabetic Zucker fa/fa rat (ZDF/Drt) and viable yellow mouse (Avy/a)”,Diabetes, 41, pp. 187-193, (1992).
J. Sturis et al., “Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat”,Am. J. Physiol., (267 Endocrinol. Metab. 30), E250-259, (1994).
J.E. Friedman et al., “Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa),”Am. J. Physiol., 261 (Endocrinol. Metab. 24), E782-788 (1991).
M. Ohneda et al., “Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT-2 and glucose incompetence”,Diabetologia, 38(2), pp. 173-179, (1995).
Smith, Christo Albertyn “Common Names of South African Plants,” Botanical Survey Memoir No 35 (Ed. E. Percy Phillips, Estelle Van Hoepen) Department of Agricultural Technical Services (Republic of South Africa) 1996 pp. 227, 350, 598, 599.
The Merck Manual of Diagnosis and Therapy, 17th Edition, 1999, Editor: Karyn A.G. Lane, Merck & Co., Inc., Chaper 13, “Disorders of Carbohydrate Metabolism”, pp. 165-185; and p. 1902.
Habeck, Drug Discovery Today (Mar. 1, 2002), 7(5):280-281. A succulent cure to end obesity.
Davies et al., Diabetic Medicine (May 2, 2004), 21(5):403-414. Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting.
Sturis et al., American J. of Physiology (1995), 269(4Pt 1):E786-92. Prevention of diabetes does not completely prevent insulin secretion defects in the ZDF rat.
Davies et al. (2004) Prevention of Type 2 Diabetes Mellitus. A review of the Evidence and Its application in a UK Setting, Diabetic Medicine, 21(5):403-414.
Sturis et al. (1995) Prevention of Diabetes Does not Completely Prevent Insulin Secretion Defects in the ZDF Rat, American J. of Physiology, 269(4Pt 1): E786-792.
The Merck Manual of Diagnosis and Therapy, 17th Edition, 1999, Editor, Keryn A.G. Lane, Merck & Co., Inc., Chapter 13, Disorders of Carbohydrate Metabolism, pp. 165-185 and p. 1902.
Thunberg, Charles Peter “Travels in Europe, Africa and Asia made between the years 1770 and 1779,” vol. 2., F. and C. Rivington 1795, pp. 140, 171.
Warburg, Otto “Die Pflazenwelt, Dritter Band” Bibliographisches Institut Leipzig 1922, p. 146 (translation of highlighted section attached).
Marloth, R. “The Flora of South Africa with synopsis of the South African genera of Phanerogamous plants” vol. III, pp. 1000-1002, Wheldon & Wesley, London 1932.
Peterson, Richard G., “The Zucker diabetic fatty (ZDF) rat,”Lessons from animal diabetes, V. Ed. E. Shafrir, pp. 225-230, (1995).
Dohm, G. Lynis, et al., “Acarbose Treatment of Non-Insulin-Dependent Diabetic Fatty (ZDF/Drt-fa) Rats Restores Expression of Skeletal Muscle Glucose Transporter GLUT4,”Drugs in Development, vol. 1, α-Glucosidase Inhibition: Potential Use
Bindra Jasjit Singh
Cawthorne Michael Anthony
Rubin Ian Duncan
Conopco Inc.
Flood Michele C.
Morgan & Lewis & Bockius, LLP
LandOfFree
Extracts, compounds and pharmaceutical compositions having... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extracts, compounds and pharmaceutical compositions having..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracts, compounds and pharmaceutical compositions having... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3993599